Nodular Lymphocyte Predominant Hodgkin Lymphoma, Lymph Nodes of Inguinal Region and Lower Limb (C81.05)

Name of the Condition

• Common Name: Nodular Lymphocyte Predominant Hodgkin Lymphoma, Lymph Nodes of Inguinal Region and Lower Limb
• Medical Terms: NLP Hodgkin Lymphoma, Lymphocyte-Predominant Hodgkin Lymphoma

Summary

Nodular lymphocyte predominant Hodgkin lymphoma (NLP Hodgkin lymphoma) is a rare subtype of Hodgkin lymphoma that originates in the lymphatic system. It is characterized by the presence of large, abnormal cells known as lymphocyte-predominant (LP) cells, which are distinct from the Reed-Sternberg cells seen in other Hodgkin lymphoma subtypes. The disease typically involves lymph nodes and may spread to other lymphoid tissues or organs. NLP Hodgkin lymphoma tends to have a more indolent course compared to other subtypes, with a higher likelihood of late relapses.

Causes

The exact cause of NLP Hodgkin lymphoma is not fully understood, but it is thought to result from a combination of genetic mutations and environmental factors. Unlike other Hodgkin lymphoma subtypes, Epstein-Barr virus (EBV) is rarely associated with NLP Hodgkin lymphoma. Research suggests that alterations in the B-cell receptor signaling pathway and other genetic abnormalities may play a role in its development.

Risk Factors

• Age: Most commonly diagnosed in adults, with a peak incidence in the 30-50 age range.
• Gender: Slightly more prevalent in males.
• Family history: A small increased risk may be present in individuals with a family history of lymphoma.

Symptoms

Symptoms may include painless swelling of lymph nodes in the inguinal region or lower limb, fatigue, unexplained weight loss, fever, or night sweats. Some patients may experience pruritus (itching) or systemic symptoms, though these are less common than in other Hodgkin lymphoma subtypes.

Diagnosis

Diagnosis involves a combination of physical examination, imaging studies (e.g., CT or PET scans), and biopsy of the affected lymph node. Histopathological analysis is required to identify LP cells and confirm the subtype. Immunohistochemistry and flow cytometry may be used to distinguish NLP Hodgkin lymphoma from other lymphomas.

Treatment Options

Treatment typically involves chemotherapy, often with regimens such as ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) or more targeted therapies like rituximab. Radiation therapy may be used for localized disease. Treatment plans are individualized based on disease stage, patient age, and overall health.

Prognosis and Follow-Up

NLP Hodgkin lymphoma generally has a favorable prognosis, with high response rates to treatment. However, late relapses can occur, necessitating long-term follow-up. Regular monitoring with physical exams, imaging, and blood tests is recommended to detect recurrence early.

Complications

Potential complications include treatment-related side effects (e.g., infertility, secondary cancers), disease progression, or relapse. Rarely, the disease may transform into a more aggressive lymphoma.

Lifestyle & Prevention

Maintaining a healthy lifestyle, including a balanced diet, regular exercise, and avoiding tobacco, may support overall health. There are no specific preventive measures for NLP Hodgkin lymphoma, as the exact causes are not fully known.

When to Seek Professional Help

Seek medical attention if you experience persistent, painless lymph node swelling, unexplained weight loss, fever, or night sweats. Early evaluation is important for accurate diagnosis and timely treatment.

Tips for Medical Coders

When coding for C81.05, ensure the documentation specifies involvement of the inguinal region and lower limb lymph nodes. Verify that the diagnosis aligns with the histopathological criteria for nodular lymphocyte predominant Hodgkin lymphoma. Accurate site-specific documentation is critical for correct code assignment.